Lexeo Therapeutics
LXEO
LXEO
89 hedge funds and large institutions have $170M invested in Lexeo Therapeutics in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $8K | Put options by funds: $8K
Holders
89
Holding in Top 10
2
Calls
$8K
Puts
$8K
Top Buyers
| 1 | +$13.2M | |
| 2 | +$11.4M | |
| 3 | +$6.93M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$6.88M |
| 5 |
Millennium Management
New York
|
+$5.8M |
Top Sellers
| 1 | -$3.9M | |
| 2 | -$2.87M | |
| 3 | -$2.24M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.48M |